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LJUNGGREN Et aL of acute renal tubular injury. [12] [13] [14] One study reported no effect on clinical outcomes after removing mannitol from the priming solution, and only economic benefits were identified. 15 There is thus no clear consensus regarding the use of mannitol during cardiac surgery, and there are only a few studies have been carried out on the effects of using mannitol in CPB prime solutions. 16 We therefore designed a prospective, randomized, double-blind study to investigate the effects of mannitol when it is used in the CPB prime solution. According to a recent report by Malmqvist et al measured plasma osmolality is a more exact way to determine electrolyte balance than calculated osmolality during CPB and it should be included in studies when the effect of CPB prime solutions evaluates. 17 Plasma osmolality was therefore measured in our study with the freezing point depression method as it is an accurate technique for determining osmolality. 18 The overall aim of this study was to investigate the perioperative effect of mannitol in the CPB prime solution compared with a prime based on Ringer's acetate following cardiac surgery in patients with normal preoperative cardiac and renal functions. We also investigated the short-time postoperative outcome including renal function.
| ME THODS

| Study design
This single-center, prospective study was designed as a randomized double-blind, control trial. The study was approved by the ethics committee of southern Sweden (no. 2017/442), and was also reported to ClinicalTrials.org, id: NCT03302286. We recruited 40 adult patients who were scheduled for elective isolated coronary artery bypass grafting (CABG) at the Department of Cardiothoracic Surgery, Anesthesia and Intensive Care, Skane University Hospital, Lund, Sweden. The flowchart for the study is presented in Figure 1 . All patients were informed orally and in writing prior to surgery by the authors, and written consent was obtained for study participation and publishing of the results.
Data collection started in September 2017 and was completed by
March 2018. Twenty patients were allocated to each arm using the sealed envelope system. Coding was performed by non-study staff and code key was revealed after the end of data collection.
Randomization was performed by non-study clinical staff who prepared the study solution and gave this to the blinded perfusionist.
The inclusion criteria were as follows: normal left ventricular function, defined as a left ventricular ejection fraction on preoperative echocardiogram of at least 50%, and normal renal function, defined as estimated glomerular filtration rate (eGFR) greater than 60 mL/min. Exclusion criteria were patient weight less than 50 kg, preoperative hematocrit less than 24% and previous history of cardiac surgery. In our study, the eGFR was the mean of the relative eGFR based on creatinine and the relative eGFR based on cystatin C. The revised Lund-Malmö equation 19 was used to calculate eGFR based on creatinine and the CAPA equation 20 
Editorial comment
In this prospective randomized double-blind study, the addition of mannitol to a priming solution for cardiopulmonary bypass (CPB) resulted in an increased diuresis and decease in sodium concentration, but no changes in osmolality, acid-base status or other electrolytes. While the study is underpowered to detect differences in clinical outcomes such as acute kidney injury, it questions the routine use of mannitol for CPB priming solution.
F I G U R E 1 Flowchart of the study sodium chloride (Fresenius Kabi AB). The mannitol group (n = 20) received a priming solution containing 1000 mL Ringer's acetate, 10 000 units heparin, and 80 mmol sodium chloride and 200 mL mannitol (Fresenius Kabi AB).
| Surgical and anesthesia protocol
All patients underwent a routine CABG through a median sternotomy.
General anesthesia was induced with midazolam, fentanyl, and propofol, whereas relaxation was achieved with rocuronium. Intravenous anesthesia was maintained by propofol and fentanyl throughout the operation. The target blood pressure during CBP was 40-80 mm Hg, norepinephrine was used when needed. A maximum of 1000 mL of Ringer's acetate could be given intravenously by the anesthetic team during the operation. Heparin was administered during CPB at a dose calculated to give an activated clotting time of 480 seconds or more.
| Cardiopulmonary circuit
The CPB setup was identical for all patients. The equipment used consisted of a Stöckert S5 ® heart-lung machine (Sorin Group Japan Co., Ltd), a CAPIOX FX25 advanced oxygenator with an integrated arterial filter, and a hard-shell venous reservoir with a volume of 4000 mL (both from Terumo Cardiovascular Group), and a Stöckert 3T heater-cooler unit and a CSC14 cardioplegia heat exchanger (both from LivaNova).
| Perfusion protocol
Standard, non-pulsatile perfusion was performed with a target cardiac index of 2.4 L/min/m. 2 Normothermia, defined as a body temperature above 36°C, was maintained during CPB. If required, patients could be given a maximum of 1000 mL additional Ringer's acetate during CPB. Myocardial protection was achieved with cold blood cardioplegia. Shed blood was collected in the venous reservoir. After weaning from CPB the blood remaining in the CPB-system was transferred to a cell saver (AutoLog ® Autotransfusion System, Medtronic) and after processing it was transfused back to the patient according to local routine.
| Data collection
Preoperative blood samples were obtained from peripheral antecubital vein the day before surgery, and analyzed at the hospital's biomedical laboratory. Per-and postoperative blood analysis was carried out according to Table 1 . Osmolality was determined using the freezing point depression method using a Fiske 210 Micro-Osmometer (Advanced Instruments Inc). Electrolytes and pH were measured in whole blood using a blood analyzer (ABL800 FLEX, Radiometer Medical ApS). Data on peri-and postoperative fluid balance, diuresis and whether any diuretics were given, were retrieved from the patients' records.
| Statistical analysis
Based on a change of 10 mOsm/kg in the osmolality and a standard deviation of 11 mOsm/kg, 21 Table 2 . All patients had sinus rhythm preoperatively. There was no incidence of postoperative confusion or stroke. There was one reoperation in each group due to postoperative bleeding. The demographic data did not differ significantly between the two groups except the postoperative length of stay at intensive care unit ( Table 2 ).
| RE SULTS
The 30-day survival was 100%. 
| Osmolality and acid-base homeostasis
| Sodium
The mean levels of sodium preoperatively did not differ between the TA B L E 2 Pre-and perioperative characteristics two groups from T2 through T6, as can be seen from Figure 2A .
The mannitol group showed a pronounced decrease in sodium, from 138.7 ± 2.8 mmol/L at T1 to 133.9 ± 2.6 mmol/L after starting CPB (T2) (P < .001). The sodium level did not vary in the 
| Potassium
No significant differences in potassium were found between the Ringer's acetate group and the mannitol group at any time (Supplementary figures). There was a significant increase in the potassium levels in the Ringer's acetate group between T1 and T2 
| Chloride
A significant difference was seen in the mean chloride levels between the groups from T2 through T7 as can be seen from Figure 2B .
The Ringer's acetate group showed an increase in chloride between T1 and T2 (108.0 ± 1.9 mmol/L and 112.4 ± 1.6 mmol/L, respectively [P < .001]), whereas no significant difference was seen between T1 and T2 in the mannitol group (106.5 ± 2.4 mmol/L and 106.9 ± 2.4 mmol/L, respectively [P = .273]).
| Renal function and fluid balance
The values describing the renal function are presented in Table 3 , 
| D ISCUSS I ON
The results of this study showed that the use of mannitol in CPB priming solution during a routine CABG did not affect osmolality, acid-base homeostasis, and renal function compared with priming based on Ringer's acetate, whereas sodium and chloride levels were significantly lower in the mannitol group than in the Ringer's acetate group.
Changes in plasma osmolality during cardiac surgery have been poorly investigated. The use of hyperosmolar CPB prime has been reported to result in a dramatic elevation of the plasma osmolality, 17 which may have negative effects on the central nervous system. 22 No studies on the impact of mannitol on plasma osmolality following CPB could be found in the literature. An increased osmolality in relation to mannitol dose has been reported by Manninen et al in neurosurgical settings. 23 We observed no effect of mannitol on osmolality, compared to a Ringer's-acetate-based prime in this study. We found T1  T2  T3  T4  T5  T6  T7 The role of mannitol in the kidney is controversial. Renal dysfunction is a serious complication after cardiac surgery, causing increased mortality and morbidity. 24 Therefore, every attempt should be made to preserve renal function during CPB. It has been found that mannitol increases renal blood flow, which may have a positive effect on renal function in a postoperative acute kidney injury following cardiac surgery. 10, 25 On the other hand, there is a body of evidence indicating increased apoptosis of endothelial cells as a result of mannitol, and that it is harmful in acute kidney injury. [26] [27] [28] Carcoana et al have revealed the complex relationship between dopamine and mannitol in patients undergoing CPB, reporting that this combination increased the microglobulin excretion rate, which is a sensitive marker of proximal renal tubular dysfunction. 29 When comparing mannitol and Hartmann's solution in CPB prime, Yallop et al found no difference in creatinine, fluid balance or diuresis. 16 We found no differences in renal parameters or fluid balance between the groups in this study. All patients had normal preoperative renal function, and no patient received any diuretic pre-or perioperatively. Interestingly, we found no difference in urine output between the groups postoperatively, but a significant increase in urine output in the mannitol group perioperatively, indicating that mannitol has a short-term effect on urine output. In concordance with the study by Yallop et al we found no clear benefit of using mannitol in CPB prime in patients with normal renal function.
A dose-related decrease in sodium following the administration of mannitol has been reported previously by Manninen et al. 23 Our results confirmed these findings, showing that the mannitol group had a significantly lower level of sodium following CABG. Apart from the plasma sodium dilution effect, mannitol causes inhibition of sodium reabsorption in renal tubules, 30 that hyponatremia is a potentially dangerous condition associated with the risk of brain edema. [31] [32] [33] Another serious condition, central pontine myelinolysis, may occur when hyponatremia is treated rapidly. 34, 35 Minimizing the risk of hyponatremia may benefit the outcome after cardiac surgery, 33 and preventing hyponatremia during CPB is most important. Prime solution without mannitol may facilitate the achievement of this goal.
Findings concerning the relation between mannitol and potassium are limited and inconsistent. Several studies have reported a significant increase in serum potassium levels when using mannitol, although these were in noncardiac surgery settings. 36, 37 We found no significant differences in potassium levels over time between the two groups. However, an increase in potassium was observed in both groups after starting CPB, as a result of cardioplegia during CPB and the ensuing substitutional treatment during the intensive care stay. The effect of mannitol on potassium levels in the cardiac surgery setting is still uncertain and requires further investigation.
Few studies have been carried out to investigating the effect of mannitol on chlorides. Manninen et al found a decrease in serum chlorides when using mannitol in neurosurgical patients. 23 In our study, the Ringer's acetate group showed a significant increase in chloride levels during CPB, compared to the mannitol group. An additional amount of Ringer's acetate, given instead of mannitol in CPB prime, may have contributed to this variation. The clinical importance of this finding remains unclear, especially bearing in mind the identical plasma osmolality in the two groups.
| Limitations
The application of our results is limited to one particular type of cardiac surgery (CABG) and to patients with normal preoperative renal function. In addition, all the patients had received a maximum of 1000 mL Ringer's acetate as part of the perioperative anesthetic fluid therapy, and there is an unknown variation in the amount of Ringer's acetate administrated to the patients, which may have had an effect on the levels of electrolytes. The main strength of our study is its design, as the randomized clinical trial allowed the investigation of the impact of mannitol as part of CPB prime, following CABG. The other strength is the use of the freezing point depression method to determine plasma osmolality.
| CON CLUS IONS
This prospective, randomized, double-blind study revealed no effect of mannitol on osmolality, compared to a CPB prime solution based on Ringer's acetate, in patients with normal cardiac and renal functions. The use of mannitol in prime resulted in a short-term, but significant, decrease in sodium. A significant increase in osmolality was seen in all patients during CABG, which cannot be attributed to mannitol, but is interpreted as the consequence of CPB. We, therefore, conclude that the role of mannitol in cardiac surgery requires further investigation.
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